Combined with a treat-to-target approach that we discussed in our last episode, advances in treatment over the last several years have greatly improved outcomes for those of us who have RA. There's no ...

There’s no single treatment plan for rheumatoid arthritis (RA). If you have this inflammatory disease, chances are you’ll need to change your medication one or more times along the way. There are many ...

DEAR DR. ROACH: Why doesn’t rheumatoid arthritis have any medicines to help treat it? — S.S.K. ANSWER: Rheumatoid arthritis is relatively common (as much as 1% of the population, with women twice as ...

Rheumatoid arthritis (RA) affects everyone differently. Generally speaking, though, most people who have RA will experience flare-ups — periods of worsening symptoms, such as joint pain and stiffness ...

Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor ...

Pregnant women who take biologic medication for rheumatoid arthritis are not running the risk of their infant developing serious/opportunistic infections, according to research presented at the 2017 ...

A recent study evaluating the use of non-infused biologics in patients diagnosed with rheumatoid arthritis demonstrated that patients who are adherent to their non-infused RA biologic medication are ...

Please provide your email address to receive an email when new articles are posted on . Data revealed “substantial” medication changes among patients with rheumatoid arthritis amid the pandemic, with ...

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...

CHICAGO -- An investigational monoclonal antibody drug targeting the PD-1 ligand on T cells was a winner in a phase II rheumatoid arthritis (RA) trial. Twelve weeks of treatment with the agent, called ...